Review and prospect of the development in the field of autoimmune liver diseases in China over the last 20 years

Huipng YAN; Yanmin LIU; Haiping ZHANG

doi:10.3969/j.issn.1001-5256.2022.04.001

Volume 38 Issue 4

Apr. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(4): 737-742

PDF( 2771 KB)

Review and prospect of the development in the field of autoimmune liver diseases in China over the last 20 years

DOI: 10.3969/j.issn.1001-5256.2022.04.001

b.
Second Department of Liver Disease Center, Beijing YouAn Hospital Affiliated to Capital Medical University, Beijing 100069, China
a.
Center of Clinical Laboratory, Beijing YouAn Hospital Affiliated to Capital Medical University, Beijing 100069, China

Research funding:

Pilot Project of Public Welfare Development and Reform of Beijing Municipal Medical Research Institutes (Jingyiyan 2021-10);

Young and Middle-aged Talent Incubation Project in the Hospital of Beijing YouAn Hospital, Capital Medical University, 2021 (Youth Innovation) (YNKTQN2021004)

More Information

Corresponding author: YAN Huipng, yhp503@126.com(ORCID: 0000-0002-1787-0067)
Received Date: 2022-01-04
Accepted Date: 2022-02-07
Published Date: 2022-04-20

Abstract

Abstract

Through big data, this paper reviews the national research projects and the academic papers published in China and globally in the field of autoimmune liver diseases in China from 2001 to 2020, revealing the development trend in the past two decades. This paper also introduces the updates of the newly issued guidelines for the diagnosis and treatment of autoimmune liver diseases, and reviews the development of autoantibody detection technology and analyzes its progress.
- Hepatitis, Autoimmune,
- Primary Biliary Cholangitis,
- Cholangitis, Sclerosing

FullText(HTML)

References(15)

References

[1]	The Committee of the Autoantibodies Detection of Rheumatology and Immunology Physicians Committee of Chinese Medical Doctor Association. Expert consensus on clinical application of autoantibodies detection in patients with autoimmune liver disease[J]. Chin J Intern Med, 2021, 60(7): 619-625. DOI: 10.3760/cma.j.cn112138-20210114-00037. 中国医师协会风湿免疫科医师分会自身抗体检测专业委员会. 自身免疫性肝病相关自身抗体检测的临床应用专家共识[J]. 中华内科杂志, 2021, 60(7): 619-625. DOI: 10.3760/cma.j.cn112138-20210114-00037.
[2]	ALVAREZ F, BERG PA. BIANCHI FB, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol, 1999, 31(5): 929-938. DOI: 10.1016/s0168-8278(99)80297-9.
[3]	GALASKI J, CHRISTINA WN, SCHAKAT M, et al. Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing[J]. J Hepatol, 2021, 74(2): 312-320. DOI: 10.1016/j.jhep.2020.07.032.
[4]	YAN HP, LIU YM, ZHANG HP. Introduction to 2015 International Symposium on Autoimmune Liver Disease[J]. Chin J Hepatol, 2015, 23(8): 32-35. DOI: 10.3760/cma.j.issn.1007-3418.2015.10.000. 闫惠平, 刘燕敏, 张海萍. 2015年肝脏自身免疫疾病国际会议简介[J]. 中华肝脏病杂志, 2015, 23(8): 32-35. DOI: 10.3760/cma.j.issn.1007-3418.2015.10.000.
[5]	Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the diagnosis and management of autoimmune hepatitis (2021)[J]. J Clin Hepatol, 2022, 38(1): 42-49. DOI: 10.3760/cma.j.cn112138-20211112-00796. 中华医学会肝病学分会. 自身免疫性肝炎诊断和治疗指南(2021)[J]. 临床肝胆病杂志, 2022, 38(1): 42-49. DOI: 10.3760/cma.j.cn112138-20211112-00796.
[6]	Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the diagnosis and management of primary biliary cholangitis (2021)[J]. J Clin Hepatol, 2022, 38(1): 35-41. DOI: 10.3760/cma.j.cn112138-20211112-00794. 中华医学会肝病学分会. 原发性胆汁性胆管炎的诊断和治疗指南(2021)[J]. 临床肝胆病杂志, 2022, 38(1): 35-41. DOI: 10.3760/cma.j.cn112138-20211112-00794.
[7]	Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021)[J]. J Clin Hepatol, 2022, 38(1): 50-61. DOI: 10.3760/cma.j.cn112138-20211109-00786. 中华医学会肝病学分会. 原发性硬化性胆管炎诊断及治疗指南(2021)[J]. 临床肝胆病杂志, 2022, 38(1): 50-61. DOI: 10.3760/cma.j.cn112138-20211109-00786.
[8]	European Association for the Study of the Liver. EASL Autoimmune hepatitis Clinical Practice Guideline[J]. J Hepatol, 2015, 63(4): 971-1004. DOI: 10.1016/j.jhep.2015.06.030.
[9]	LINDOR KD, BOWLUS CL, BOYER J, et al. Primary Biliary Cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases[J]. Hepatology, 2021. DOI: 10.1002/hep.32117.[Online ahead of print]
[10]	SHEN F, ZHANG HP, WANG J, et al. Detection of autoimmune liver disease related autoantibodies: A report from 2012-2018 national wide survey[J]. Chin J Rheumatol, 2020, 24(11): 736-742. DOI: 10.3760/cma.j.c141217-20200205-00041. 沈芳, 张海萍, 王晶, 等. 2016-2018年全国自身免疫性肝病相关自身抗体检测质量调查评价[J]. 中华风湿病学杂志, 2020, 24(11): 736-742. DOI: 10.3760/cma.j.c141217-20200205-00041.
[11]	ZHONG RQ, YANG ZX. New era in autoantibodies detection: quantitation[J]. Chin J Lab Med, 2014, 37(8): 561-563. DOI: 10.3760/cma.j.issn.1009-9158.2014.08.001. 仲人前, 杨再兴. 自身抗体检测进入定量检测时代[J]. 中华检验医学杂志, 2014, 37(8): 561-563. DOI: 10.3760/cma.j.issn.1009-9158.2014.08.001.
[12]	European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis[J]. J Hepatology, 2017, 67(1): 145-172. DOI: 10.1016/j.jhep.2017.03.022.
[13]	WEI Y, LI Y, YAN L, et al. Alterations of gut microbiome in autoimmune hepatitis[J]. Gut, 2020, 69(3): 569-577. DOI: 10.1136/gutjnl-2018-317836.
[14]	CZAJA AJ. Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions[J]. World J Gastroenterol, 2019, 25(45): 6579- 6606. DOI: 10.3748/wjg.v25.i45.6579
[15]	WANG L, HAN Y. Diagnosis and treatment of primary biliary cholangitis: Current status and challenges[J]. J Clin Hepatol, 2021, 37(10): 2257-2261. DOI: 10.3969/j.issn.1001-5256.2021.10.001.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(5)

Get Citation

PDF

XML

Article Metrics

Article views (956) PDF downloads(199)

Review and prospect of the development in the field of autoimmune liver diseases in China over the last 20 years

DOI: 10.3969/j.issn.1001-5256.2022.04.001

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Review and prospect of the development in the field of autoimmune liver diseases in China over the last 20 years

DOI: 10.3969/j.issn.1001-5256.2022.04.001

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content